Lilly stops mid-stage Alzheimer's drug study (Update)
Eli Lilly and Co. said Thursday that it stopped a mid-stage clinical trial of an experimental Alzheimer's disease drug because of potential side effects on patients' livers.
Eli Lilly and Co. said Thursday that it stopped a mid-stage clinical trial of an experimental Alzheimer's disease drug because of potential side effects on patients' livers.
Bringing a new medicine to market in Africa requires 54 separate applications to each country on the continent, a time-intensive process that could be costing lives. African leaders are now trying to move toward a regional ...
Zydus Pharmaceuticals is recalling a single lot of the drug warfarin after receiving a complaint that some of the tablets are too large.
Two generic drugmakers will pay $2.15 billion to Pfizer and Takeda Pharmaceutical to settle a patent fight over the heartburn treatment Protonix.
A government appeal in the legal fight over allowing girls of any age to buy emergency contraception without prescriptions has officially been put on hold.
Scientists at UC Irvine reported this week that a synthetic compound ShK-186, originally derived from a sea anemone toxin, has been found to enhance metabolic activity and shows potential as a treatment for obesity and insulin ...
US government health experts are recommending changes to safety restrictions on former blockbuster diabetes pill Avandia, in light of a new analysis suggesting that the drug may not increase the risk of heart attack as previously ...
Don't look for the morning-after pill to move next to the condoms on drugstore shelves right away. But after a fight that's last more than a decade, it appears it really will happen. Backed into a corner ...
The U.S. Drug Enforcement Administration has reached an $80 million civil settlement with the Walgreens pharmacy chain over violations of rules governing the distribution of powerful prescription painkillers.
NJIT Assistant Professor Mei Liu, PhD, a computer scientist, has recently shown in a new study that electronic medical records can validate previously reported adverse drug reactions and report new ones.
GlaxoSmithKline's controversial diabetes drug Avandia, restricted in the US and banned in Europe over concerns it raises heart attack risk, is getting a second look this week by US medical experts.
The Obama administration said Monday it would comply with a judge's order to allow women and girls of any age to purchase emergency contraception, ending its efforts to restrict the drug's availability.
Evergreening strategies—where pharmaceutical companies slightly change the formulation of their brand drug into "follow on" drugs by combining formulations or producing slow-release forms, for example, so that they can ...
(HealthDay)—The drugs emerging from clinical trials in recent years seem less impressive than those developed in decades gone by, a new review finds.
Johnson & Johnson is conducting a voluntary recall of millions of oral contraceptive packages in 43 countries outside the U.S., but the health care giant says there's a "very low" risk that the flawed tablets could cause ...